Antibiotic impregnated Hydrocephalous Catheter + Clindamycin - India CDSCO Medical Device Registration

Antibiotic impregnated Hydrocephalous Catheter + Clindamycin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000050_d603c36c88ead8136df976f177cde67f_abc0ce70d3dfc71037c3b08c0f1b43e6. This device is marketed under the brand name Onyx TruCor Zotarolimus-Eluting Coronary Stent System. The license holder is India Medtronic Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Antibiotic impregnated Hydrocephalous Catheter + Clindamycin

UID: IMP/MD/2019/000050_d603c36c88ead8136df976f177cde67f_abc0ce70d3dfc71037c3b08c0f1b43e6

Brand Name

Onyx TruCor Zotarolimus-Eluting Coronary Stent System

License Holder

India Medtronic Private Limited

Device Class

Class D

Approving Authority

CDSCO

Product Information

It is intended for use in the treatment of hydrocephalous as a component of a shunt system when draining or shunting of cerebrospinal fluid (Onyx TruCor Zotarolimus-Eluting Coronary Stent System) is indicated